Board of directors

Sol-Gel directors includes industry veterans as well as world-leading scientists in the fields of dermatology, pharmaceuticals and microencapsulation. Years of applied experience, and deep cross-functional expertise equips Sol-Gel with unique qualities and capabilities.

doctor-2
Mr. Haim Bar-Simantov
Chief Operating Officer

An industry expert, Mr. Bar Simantov leads Sol-Gel’s pharmaceutical development, manufacturing, supply and commercialization processes. Mr. Bar Simantov, inventor of several patents related to drug products, provides enormous practical value to the successful operation of Sol-Gel. 

doctor-2
Dr. Ofra Levy-Hacham
VP Quality Assurance and Regulatory Affairs

An experienced specialist in manufacturing control, QA and QC management, drug discovery and regulatory affairs, Dr. Levy-Hacham directs Sol-Gel’s Quality Systems and Compliance Initiatives. Dr. Levy-Hacham, formerly the VP of CMC at HealOr Ltd., head of QA at Bio-Technology General and other pharmaceutical companies, received her PhD in Chemistry from the Israel Institute of Technology.

doctor-2
Dr. Ofer Toledano
VP Research and Development

Overseeing the development of Sol-Gel’s drug formulation and delivery systems, Dr. Toledano is an expert in micro-encapsulation with extensive experience managing R&D. Dr. Toledano was the manager of the Formulation Department at Makhteshim Chemical Works prior to joining Sol-Gel. Dr. Toledano received his PhD in chemistry from the Hebrew University of Jerusalem.

doctor-2
Dr. Alon Seri-Levy
Co-Founder and Chief Executive Officer

Dr. Seri-Levy serves as CEO and member of the board. Prior to founding Sol-Gel, he established the Computer-Aided Drug Design department at Peptor Ltd. Dr. Seri-Levy received his PhD in Chemistry summa cum laude from the Hebrew University of Jerusalem and completed post-doctorate studies at Oxford University.

doctor-2
Mr. Moshe (Mori) Arkin
Chairman

Mr. Arkin, healthcare entrepreneur and a dermatology industry veteran, served as Chairman of Agis Industries Ltd. since its inception in 1983 until its acquisition by Perrigo Company in 2005 for $850M. After serving on Perrigo's board of directors, Mr. Arkin established Arkin Holdings – a family office through which he invests and navigates several companies in the healthcare industry. In 2014, Mr. Arkin acquired Sol-Gel, aiming to leverage his wide experience in both branded & generic dermatology in order to turn Sol-Gel into a market leader.

doctor-2
בדיקה
CEO

microencapsulation delivery system, consisting of microcapsules made of precipitated silica. Based on our pre-clinical and clinical data, we expect this delivery system will enable us to develop and commercialize dermatological drug products that are more effective or have fewer side effects than currently marketed drugs.

doctor-2
Media Confidence Index

Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and coializing topical dermatological drug products.
Sol-Gel is a clinical-stage specialty pharmaceutical company focused  commercializing dermatolol drug products.eveloping and commercializing topical dermatological dru
ing topiatological dru

doctor-2
Dr.Addison_Alexander
VP Quality Assurance and Regulatory Affair

Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and coializing topical dermatological drug products.
Sol-Gel is a clinical-stage specialty pharmaceutical company focused  commercializing dermatolol drug products.eveloping and commercializing topical dermatological dru
ing topiatological dru
 

doctor-2
Media Derived Indicators
fgas

הלחעדלחכי דגשלחילח ידשלךיכע חלשדי חלשדי ךלשילךהילךסבה לךש ןעטשולהילך ןשדי ןשגיעןשילך שידגליה לשדגח גךלכע שגכעשדגכעש גכע שגכ ע

doctor-2
Earnings Prediction Technology

Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and coializing topical dermatological drug products.
Sol-Gel is a clinical-stage specialty pharmaceutical company focused  commercializing dermatolol drug products.eveloping and commercializing topical dermatological druing topiatological dru